Drug & Medication
Table of Contents
Around three quarters of the US$36.4 billion respiratory prescription drugs market comprises drugs that are delivered using inhalation or nasal spray technologies. The top five drugs used in the treatment of asthma and chronic obstructive pulmonary disease (COPD) attracted combined revenues of around US$18.0 billion in 2012. All five are blockbuster drugs. The current market leader overall is GlaxoSmithKline’s Seretide/Advair (fluticasone propi...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Louis
+1 718 618 4302
PharmaPoint: Prophylactic Hepatitis B Virus Vaccines - Global Drug Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute o ...
PharmaPoint: Crohn's Disease - Global Drug Forecast and Market Analysis to 2022 Summary The Crohn's disease (CD) market is currently very dynamic, with novel biologic therapies on the horizon, such as ...
REPORT HIGHLIGHTS The global market for ADC drugs reached $179 million in 2012 and $396 million in 2013. The market should reach $2.8 billion in 2018 with a compound annual growth rate (CAGR) of 48.1%. ...
... Hg introduces new recommendations designed to promote safer use of angiotensin converting enzyme inhibitors (aceis) and angiotensin receptor blockers (arbs) first-line and later-line treatment should now ...
... vaccination 1988: before the global polio eradication initiative endemic non-endemic who. Global polio eradication initiative. Available at: http ...
Reportlinker.com © Copyright 2014. All rights reserved.